Breaking News

EMD Serono Appoints Neurology, Immunology VP

September 4, 2014

Young brings more than 20 years of experience

Drew Young has been appointed senior vice president of Neurology and Immunology at EMD Serono, Inc. Mr. Young will be responsible for leading the strategic direction of the U.S. Neurology and Immunology franchise, including future products. 
 
He has more than 20 years of experience leading global and U.S. marketing and sales efforts at pharma and biopharma companies. He joins the company from Biogen Idec, where he was the marketing lead of the interferon franchise for the multiple sclerosis (MS) business.
 
"Drew is a proven commercial leader and a key addition to EMD Serono's strengthened leadership team," said Gary Zieziula, chief commercial officer of EMD Serono. "His knowledge and experience in MS and proven track record of commercial success, will add to our organization's continued drive to innovate on behalf of the MS patient community."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks